Status:
COMPLETED
Mindfulness and HEP in Dialysis Patients With Depression and Anxiety
Lead Sponsor:
Lady Davis Institute
Collaborating Sponsors:
McGill University Health Centre/Research Institute of the McGill University Health Centre
University of Toronto
Conditions:
Renal Disease
Depression
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
This pilot clinical trial examines the acceptability of meditation techniques versus health promotion in people receiving dialysis who have anxiety or depression. 50% of people who undergo dialysis ex...
Detailed Description
Background Dialysis patients are prone to lower increased non-adherence, suicidal behavior, medical comorbidity, mortality and low quality of life. As a result of illness burden in dialysis, treatment...
Eligibility Criteria
Inclusion
- Aged 18yrs.\>
- Currently receiving maintenance hemodialysis, with depression (Patient Health Questionnaire (PHQ-9) score ≥6) and/or anxiety (General Anxiety Disorder-7 (GAD- 7) score ≥6).
- Normal cognition or Mild Cognitive Impairment will be addressed on a normal screening result on the 3-minute Mini-Cog Test (53).
- Patients should have sufficient hearing to follow verbal instructions, be able to sit for 20-25 minutes without discomfort
- Have adequate understanding of English and/or French
Exclusion
- Mild, Moderate, or Severe Dementia ("Abnormal" Result on the 3-minute Mini-Cog Test (53))
- Acute psychotic symptoms,
- Acute suicidal ideation/intent
- Patients currently receiving active psychotherapy
Key Trial Info
Start Date :
May 10 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03406845
Start Date
May 10 2018
End Date
June 30 2019
Last Update
August 20 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Lady David Institute
Montreal, Quebec, Canada, H3T 1E2
2
McGill University Health Centre
Montreal, Quebec, Canada